Characterization of Arrhythmia-induced Cardiomyopathy

RecruitingOBSERVATIONAL
Enrollment

2,700

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions
CardiomyopathyArrhythmia-induced Cardiomyopathy (AiCM)
Interventions
OTHER

Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)

Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part). The assessment will be done via mail, letter or phone

OTHER

Data collection: Quality of Life (QoL) Questionnaire (prospective part)

"Data collection: Quality of Life (QoL) Questionnaire (prospective part). The questionnaire EQ-5D-5L questionnaire will be used to assess quality of life."

OTHER

Data collection (retrospective study)

Anonymized search and review of patients electronic health records of the University Hospital of Basel for patients with a reduced LVEF and a concomitant (±1year or after any observation of a reduced LVEF in imaging) diagnosis of arrhythmia known to be causing AiCM.

OTHER

Data collection (prospective study database)

Data collection on alcohol consumption, family history, rhythm disorder, hospitalizations, cardiac assessments, adverse events at baseline, 6 months, 1 year, 2 years and 5 years.

Trial Locations (1)

4031

RECRUITING

University Hospital Basel, Department of Cardiology, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER